Sepracor Pharmaceuticals Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Sepracor Pharmaceuticals General Information
Description
Provider of pharmaceutical products. The company is a specialty pharmaceutical company that in-licenses and markets branded prescription pharmaceutical products to physician specialists and hospitals within Canada and is focused in the cardiovascular, central nervous system (CNS) disorders, pain and infectious disease therapeutic areas.
Contact Information
Website
www.oryxpharma.comCorporate Office
- 6500 Kitimat Road
- Mississauga, Ontario L5N 2B8
- Canada
Corporate Office
- 6500 Kitimat Road
- Mississauga, Ontario L5N 2B8
- Canada
Sepracor Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sepracor Pharmaceuticals FAQs
-
When was Sepracor Pharmaceuticals founded?
Sepracor Pharmaceuticals was founded in 2001.
-
Where is Sepracor Pharmaceuticals headquartered?
Sepracor Pharmaceuticals is headquartered in Mississauga, Canada.
-
What industry is Sepracor Pharmaceuticals in?
Sepracor Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Sepracor Pharmaceuticals a private or public company?
Sepracor Pharmaceuticals is a Private company.
-
What is the current valuation of Sepracor Pharmaceuticals?
The current valuation of Sepracor Pharmaceuticals is .
-
What is Sepracor Pharmaceuticals’s current revenue?
The current revenue for Sepracor Pharmaceuticals is .
-
When was Sepracor Pharmaceuticals acquired?
Sepracor Pharmaceuticals was acquired on 04-Jun-2008.
-
Who acquired Sepracor Pharmaceuticals?
Sepracor Pharmaceuticals was acquired by Sunovion Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process